BIRC5 and cervical carcinoma: In this premise, we first investigated the Survivin-inhibitory potential of Wi-A and Wi-N concerning YM-155 using a computational approach and validated the findings by in vitro experiments treating cervical cancer cells (HeLa and ME-180) with Wi-A-rich Ashwagandha leaf (Wi-AREAL) extract.